English
Protein-protein interactions during the secretion of neurotransmitters and local hormones or events downstream of receptor binding are difficult to study in a physiological context in situ. Although many of the players and their interactions are known, the dynamics of interactions within a cell physiology context are not because they are difficult to measure. One approach is to apply an inhibitory peptide in a spatially localised and time-resolved experiment, measuring the resulting changes in amplitude and time-course of physiological responses. This proposal takes developments in the photochemistry of one or two-photon uncaging and of peptide chemistry, particularly cell penetrating peptides (CPPs), to develop tools for the time resolved dissection of protein-protein interactions during cellular secretion and synaptic transmission. The approach is interdisciplinary, bringing together expertise in one and two-photon excitation, in development and application of CPPs, and cellullar secretion and synaptic transmission to probe protein-protein interactions during intracellular processes. By ‘caging’ critical residues to block binding, inhibitory peptides will be developed that become active only upon photolysis. Because the processes to be targeted are mainly intracellular, CPPs will permit access to the intracellular compartments; the spatial and time-resolved precision will be provided by one or two-photon photolysis in the experimental microscope. To develop specific probes there are 3 technical aspects that need to be optimised and integrated. First, intracellular access of caged peptides is usually by microinjection or perfusion from patch pipettes. CPPs will be developed to permit access of the inactive caged peptide to many cells within a tissue before release of the active peptide by photolysis localised to the structure of interest. Second, caging groups with enhanced two-photon cross-sections will be developed. Third, the caged CPP-peptide inhibitor conjugates will be tested for reduced binding affinity and biological/pharmacological inertness. Cell penetrating peptides. The proposal will develop efficient intracellular delivery for bioactive cargoes, quantifying uptake and mechanisms with MALDI-TOF mass spectrometry. New approaches are CPPs with basic domains functionalised with fatty acids, entering cells mainly by direct translocation. Rigid cyclic peptides will be developed and structures favoring direct translocation selected. Methods of ligation are also being developed to facilitate synthesis. Identifying structural elements that promote cytosolic translocation in combination with functional assays of CPP-caged inhibitors should lead to the development of new CPPs with improved properties. Photochemistry of one and two-photon cages. Caging groups with high one and two photon cross-sections, high water solubility and suitable for protecting amino N-terminal or lysine groups, sulfhydryls, alcohols or carboxylates are being developed around dimethylamino quinoline photochemistry. Endothelial cell secretion. Vascular endothelial cells regulate hemostasis, inflammation, vessel growth and repair and also provide a good model test system in culture for protein interactions during secretion. The molecules involved have been identified and molecular interventions and optical miroscopy are readily applied. Experiments will target syntaxin 2 related peptides, calmodulin inhibitory peptides and PKC inhibitory peptide. Synaptic transmission. Extracellular caged peptide inhibitors of AMPA subtype of glutamate receptor will be used to distinguish fast single site transmission from slow multi synapse spill-over and parasynaptic transmission at specific synapses in the cerebellar cortex. Intracellularly, caged peptides that interfere with receptor localisation at identifiable synapses after photolysis will be used to probe the time-course of changes in synaptic strength during burst stimulation.
